Serum hyaluronic acid levels in patients with ankylosing spondylitis

Clinical Rheumatology

Volumn 27, Issue 5, 2008, Pages 621-626

  Duruöz, Mehmet Tuncay ^a   Turan, Yasemin ^b   Cerrahoglu, Lale ^a   Isbilen, Banu ^a  

^a CELAL BAYAR UNIVERSITY   (Turkey)

^b ADNAN MENDERES UNIVERSITY   (Turkey)

Author keywords

Ankylosing spondylitis; Disease severity; Hyaluronic acid

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; HYALURONIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; SALAZOSULFAPYRIDINE;

ADULT; ANKYLOSING SPONDYLITIS; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMOGRAPHY; DIAGNOSTIC VALUE; DISEASE ACTIVITY; DISEASE SEVERITY; FEMALE; FUNCTIONAL STATUS; HUMAN; INFLAMMATION; LABORATORY TEST; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SACROILIITIS; SHORT FORM 36; SPINE MOBILITY;

ADULT; CASE-CONTROL STUDIES; FEMALE; HUMANS; HYALURONIC ACID; MALE; MIDDLE AGED; SACROILIAC JOINT; SPINE; SPONDYLITIS, ANKYLOSING;

EID: 41849128514     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-007-0757-0     Document Type: Article

References (31)

1. Khan MA (2002) Ankylosing spondylitis: Introductory comments on its diagnosis and treatment. Ann Rheum Dis 61(Suppl 3):3-7
2. Khan MA (2002) Update on spondyloarthropathies. Ann Intern Med 136:896-907
3. Van der Linden S, Van der Heijde D, Braun J (2005) Spondyloarthropathies: Ankylosing Spondylitis. In: Harris ED (ed) Kelley's textbook of Rheumatology, 7th edn. Elsevier, Philadelphia, pp 1125-1142
4. Garnero P, Rousseau JC, Delmas PD (2000) Molecular basis and clinical use of biochemical markers of bone, cartilage, and synovium in joint diseases. Arthritis Rheum 43:953-968
5. Wells AF, Klareskog L, Lindblad S, Laurent TC (1992) Correlation between increased hyaluronan localized in arthritic synovium and the presence of proliferating cells: A role for macrophage-derived factors. Arthritis Rheum 35:391-396
6. Laurent TC, Dahl IM, Dahl LB, Engstrom-Laurent A, Eriksson S, Fraser JR et al (1986) The catabolic fate of hyaluronic acid. Connect Tissue Res 15:33-41
7. Hallgren R, Engstrom-Laurent A, Nisbeth U (1987) Circulating hyaluronate: A potential marker of altered metabolism of the connective tissue in uremia. Nephron 46:150-154
8. Wilkinson CR, Bower LM, Warren C (1996) The relationship between hyaluronidase activity and hyaluronic acid concentration in sera from normal controls and from patients with disseminated neoplasm. Clin Chim Acta 256:165-173
9. Manley G, Warren C (1987) Serum hyaluronic acid in patients with disseminated neoplasm. J Clin Pathol 40:626-630
10. Faber J, Horslev-Petersen K, Perrild H, Lorenzen I (1990) Different effects of thyroid disease on serum levels of procollagen III N-peptide and hyaluronic acid. J Clin Endocrinol Metab 71:1016-1021
11. Ozasa H, Chichibu K, Tanaka Y, Kondo T, Kitajima K, Ota K (1992) Relationship between plasma levels of hyaluronic acid and amyloid-associated osteoarthropathy in chronic hemodialysis patients. Nephron 61:187-191
12. Engstrom-Laurent A, Hallgren R (1985) Circulating hyaluronate in rheumatoid arthritis: Relationship to inflammatory activity and the effect of corticosteroid therapy. Ann Rheum Dis 44:83-88
13. Lundin A, Engstrom-Laurent A, Hallgren R, Michaelsson G (1985) Circulating hyaluronate in psoriasis. Br J Dermatol 112:663-671
14. Goldberg LR, Huff JP, Lenz ME, Glickman P, Katz R, Thonar EJMA (1991) Elevated plasma levels of hyaluronate in patients with osteoarthritis and rheumatoid arthritis. Arthritis Rheum 34:799-807
15. Turan Y, Bal S, Gurgan A (2007) Serum Hyaluronic Acid Levels in Patients with Knee Osteoarthritis. Clinical Rheumatol 26(8):1293-1298
16. Van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis: A proposal for the modification of the New York criteria. Arthritis Rheum 27:361-368
17. Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A (1994) A new approach to defining disease status in ankylosing spondylitis: The Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 21:2286-2291
18. Calin A, Garrett S, Whitelock H, Kennedy LG, O'Hea J, Mallorie P, Jenkinson T (1994) A new approach to defining functional ability in ankylosing spondylitis: The development of the Bath Ankylosing Spondylitis Functional Index (BASFI). J Rheumatol 21:2281-2285
19. Akkoc Y, Karatepe AG, Akar S, Kirazli Y, Akkoc N (2005) A Turkish version of the Bath Ankylosing Spondylitis Disease Activity Index: reliability and validity. Rheumatol Int 25(4):280-284
20. Yanik B, Gursel YK, Kutlay S, Ay S, Elhan AH (2005) Adaptation of the Bath Ankylosing Spondylitis Functional Index to the Turkish population, its reliability and validity: Functional assessment in AS. Clin Rheumatol 24(1):41-47
21. Ware JE Jr (2000) SF-36 Health Survey Update. Spine 25:3130-3139
22. Mander M, Simpson JM, Mc Lellan A, Walker D, Goodacre JA, Dick WC (1987) Studies with an enthesis index as a method of clinical assessment in ankylosing spondylitis. Ann Rheum Dis 46:197-202
23. Emlen W, Niebur J, Flanders G, Rutledge J (1996) Measurement of serum hyaluronic acid in patients with rheumatoid arthritis: Correlation with disease activity. The J Rheumatol 23:974-978
24. Paimela L, Heiskanen A, Kurki P, Helve T, Repo ML (1991) Serum hyaluronate level as a predictor of radiologic progression in early rheumatoid arthritis. Arthritis and Rheum 34:815-821
25. Levesque H, Delpech B, Le Loet X, Deshayes P (1988) Serum hyaluronate in rheumatoid arthritis: Study by affino-immunoenzymatic. Br J Rheumatol 27(6):445-449
26. Francois RJ, Gardner DL, Degrave EJ, Bywaters EG (2000) Histopathologic evidence that sacroiliitis in ankylosing spondylitis is not merely enthesitis. Arthritis Rheum 43:2011-2024
27. Khan MA (2003) Spondyloarthropathies: Clinical features of ankylosing spondylitis. Rheumatology, 4th edn. In: Hochberc MC, Silman AJ, Smolen JS, Weinblatt ME, Weishman MH (eds) Toronto, pp. 1161-1181
28. Nishida Y, D'Souza AL, Thonar EJM, Knudson W (2000) Stimulation of hyaluronan metabolism by interleukin α in human articular cartilage. Arthritis Rheum 43:1315-1326
29. Sharif M, George E, Shepstone L, Knudson W, Thonar EJ, Cushnaghan J, Dieppe P (1995) Serum Hyaluronic Acid level as a predictor of disease progression in osteoarthritis of the knee. Arthritis Rheum 38:760-767
30. Horslev-Petersen K, Bentsen KD, Engström-Laurent A, Junker P, Halberg P, Lorenzen I (1988) Serum amino terminal type III procollagen peptide and serum hyaluronan in rheumatoid arthritis: Relation to clinical and serological parameters of inflammation during 8 and 24 months treatment with levamisole, penicilamine, or azothioprine. Ann Rheum Dis 47:116-126
31. Elkayam O, Yaron I, Shirazi I, Yaron M, Caspi D (2000) Serum levels of hyaluronic acid in patients with psoriatic arthritis. Clin Rheumatol 19:455-457